Mammogram Facilities, Tumor Biology Linked to the Racial Disparity in Breast Cancer

Share this content:

the Cancer Therapy Advisor take:

Screening facility resources and aggressiveness of tumors were identified as being two major factors that explain racial/ethnic disparity among patients recently screened for symptomatic breast cancer, according to an article published online in the journal Cancer Epidemiology, Biomarkers & Prevention.

Participants in this study included patients recently diagnosed with breast cancer and analyzed regarding the probability of symptomatic awareness despite a recent screening mammogram (SADRS). Patients who did not report a recent prior screening were not included in the study analyses.

Results showed SADRS was more common among nH b P=0.0004). Furthermore, an association was identified between SADRS and estrogen and progesterone receptor (ER/PR) negative status and higher grade disease.

SADRS was less likely to be reported at centers with dedicated radiologists and site that were labeled as breast imaging centers of excellence.

Two-thirds of the racial/ethnic disparity in SADRS was explained by tumor biology and facility factors (proportion mediated=70%, P=0.02).

Women with low-grade serous carcinoma of the ovary or peritoneum who are under the age of 35 face wo
Screening facility resources and aggressiveness of tumors identified as being two major factors that explain racial disparity in breast cancer.
1Division of Epidemiology and Biostatistics, University of Illinois Chicago 2Metropolitan Chicago Breast Cancer Task Force 3University of Illinois at Chicago College of Medicine Division of Hematology and Oncology 4Institute for Health Research and Policy, uic ↵*Corresponding Author: Garth H. Rauscher, Division of Epidemiology and Biostatistics, University of Illinois Chicago, School of Public Health, 816 SPHPI (M/C 923), 1603 W.
READ FULL ARTICLE From cebp.aacrjournals.org

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs